Table 1.
Participant characteristics among male injection drug users with HCV (n=56), HBV (n=6), and HIV (n=19) in Arak, Iran, 2012.*
| Variable | Overall Participant Characteristics N=100 N (%) |
HCV antibody positive N=56 N (%) |
HBV surface antigen positive N=6 N (%) |
HIV antibody positive N=19 N (%) |
|---|---|---|---|---|
|
| ||||
| Age category (years) | ||||
| <25 | 12 (12%) | 4 (7%) | 0 | 1 (5%) |
| 26–35 | 53 (53%) | 28 (50%) | 4 (67%) | 9 (47%) |
| 36–45 | 28 (28%) | 21 (38%) | 2 (33%) | 9 (47%) |
| >46 | 7 (7%) | 3 (5%) | 0 | 0 |
| median (years) | 33.3 | 32.5 | 32.5 | 34 |
|
| ||||
| Rural resident | 9 (9%) | 3 (5%) | 0 | 1 (5%) |
| Urban resident | 91 (91%) | 53 (95%) | 6 (100%) | 18 (95%) |
|
| ||||
| Marital status | ||||
| Married | 33 (33%) | 16 (29%) | 0 | 1 (5%) |
| Never married | 51 (51%) | 29 (52%) | 3 (50%) | 10 (53%) |
| Divorced | 14 (14%) | 10 (18%) | 3 (50%) | 7 (37%) |
| Widowed | 2 (2%) | 1 (2%) | 0 | 1 (5%) |
|
| ||||
| Education | ||||
| Illiterate | 1 (1%) | 0 | 0 | 0 |
| Attended secondary | 24 (24%) | 14 (25%) | 2 (33%) | 7 (37%) |
| Graduated secondary | 45 (45%) | 23 (41%) | 3 (50%) | 7 (37%) |
| Diploma | 28 (28%) | 18 (32%) | 1 (17%) | 4 (21%) |
| Academic degree | 2 (2%) | 1 (2%) | 0 | 1 (5%) |
|
| ||||
| Currently employed | 83 (83%) | 48 (86%) | 6 (100%) | 18 (95%) |
|
| ||||
| History of imprisonment | 73 (73%) | 46 (82%) | 6 (100%) | 17 (89%) |
|
| ||||
| Duration of imprisonment | ||||
| None | 27 (27%) | 10 (18%) | 0 (0%) | 2 (11%) |
| <1 year | 44 (44%) | 28 (50%) | 2 (33%) | 7 (37%) |
| >1 year | 29 (29%) | 18 (32%) | 4 (67%) | 10 (53%) |
|
| ||||
| Reported Drug Use: | ||||
| Heroin | 93 (93%) | 54 (96%) | 6 (100%) | 18 (95%) |
| Opium | 59 (59%) | 38 (68%) | 5 (83%) | 13 (68%) |
| Kerack | 49 (49%) | 32 (57%) | 5 (83%) | 15 (79%) |
| Methamphetamines | 25 (25%) | 15 (27%) | 3 (50%) | 8 (42%) |
| Cannabis | 22 (22%) | 15 (27%) | 2 (33%) | 4 (21%) |
| Norgesic – aspirin, caffeine, orphenadrin | 9 (9%) | 7 (13%) | 0 | 2 (11%) |
| Buprenorphin | 5 (5%) | 1 (2%) | 0 | 5 (26%) |
|
| ||||
| Age at first injection (years) | ||||
| <18 | 24 (24%) | 20 (36%) | 5 (83%) | 10 (53%) |
| 18–40 | 75 (75%) | 30 (54%) | 1 (17%) | 6 (32%) |
| >40 | 1 (1%) | 6 (11%) | 0 (0%) | 3 (16%) |
|
| ||||
| Any history of syringe sharing | 54 (54%) | 42 (75%) | 6 (100%) | 17 (89%) |
|
| ||||
| Syringe sharing in prison | 25 (25%) | 21 (38%) | 5 (83%) | 13 (68%) |
|
| ||||
| Sexual behavior | ||||
| None | 27 (27%) | 10 (18%) | 0 (0%) | 3 (16%) |
| Sex with women | 64 (64%) | 39 (70%) | 5 (83%) | 12 (63%) |
| Sex with men | 1 (1%) | 1 (2%) | 0 (0%) | 1 (5%) |
| Sex with men and women | 8 (8%) | 6 (11%) | 1 (17%) | 3 (16%) |
|
| ||||
| Sex with partner believed to have hepatitis | 9 (9%) | 8 (14%) | 2 (33%) | 4 (21%) |
|
| ||||
| Sex with IDU partners | 14 (14%) | 11 (20%) | 3 (50%) | 4 (21%) |
|
| ||||
| History of tattooing | 78 (78%) | 45 (80%) | 6 (100%) | 15 (79%) |
|
| ||||
| History of surgery | 42 (42%) | 24 (43%) | 4 (67%) | 10 (53%) |
|
| ||||
| History of blood transfusion | 11 (11%) | 4 (7%) | 0 (0%) | 3 (16%) |
|
| ||||
| Dentistry procedure | 50 (50%) | 33 (59%) | 3 (50%) | 14 (74%) |
|
| ||||
| Alcohol consumption | 68 (68%) | 39 (70%) | 6 (100%) | 17 (89%) |
*
Participants with HCV, HBV, and HIV co-infection are included in multiple columns.